Monthly Archives: August 2010

Allergan, Inc. Receives FDA Approval for LUMIGAN® 0.01% as First-Line Therapy Indicated for the Reduction of Elevated …

IRVINE, Calif.–(BUSINESS WIRE)–Allergan, Inc. (NYSE:AGN) today announced the United States Food and Drug Administration (FDA) has approved LUMIGAN® (bimatoprost ophthalmic solution) 0.01% as a first-line therapy indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension. Continue reading

Posted in Uncategorized | Tagged , , , , , , , | Leave a comment

Keep your desktop desktop tidy Mendeley style – Quantum Tunnel …

Light is allowed to enter our eyes through a transparent covering called the cornea . The cornea is also responsible for refracting light onto the retina to allow us to see. Damaged corneas are the second highest cause of blindness in … Continue reading

Posted in cornea, eye alternative treatment | Tagged , , , , , , , , | Leave a comment

Reportlinker Adds Drug Delivery Technologies: Players, products & prospects to 2018

Reportlinker.com announces that a new market research report is available in its catalogue: Continue reading

Posted in Uncategorized | Tagged , , | Leave a comment

Reportlinker Adds Drug Delivery Technologies: Players, products & prospects to 2018

Reportlinker.com announces that a new market research report is available in its catalogue: Continue reading

Posted in Uncategorized | Tagged , , | Leave a comment

Good News for Alimera’s Pipeline

Recently, Alimera Sciences’ pipeline received a boost when the US Food and Drug Administration accepted the New Drug Application for its lead candidate, Iluvien. Furthermore, the agency has decided to review the application on a priority basis. Continue reading

Posted in Uncategorized | Tagged | Leave a comment